Can You Buy Anthropic Stock Before the IPO?
Erik James Roberts — Founder & CIO, Infinitus Wealth Management. Purple Heart recipient, Wharton MBA.
Updated October 8, 2026
Can you buy Anthropic stock before the IPO? Not through a regular brokerage account, and most of the “pre-IPO Anthropic” products being marketed right now will not get you recognized shares either. The real answer has three parts: a narrow, board-approved path that exists for accredited investors, an IPO allocation process that favors institutions, and a public listing that reports place as soon as November 2026. This article walks through each one so you can evaluate any offer with clear eyes.
Pre-IPO Investing Is Available to Infinitus Clients
Infinitus clients have access to pre-IPO investing in select late-stage private companies. These are businesses that have not yet listed on a public exchange, the stage where much of a company's growth now happens before everyday investors can buy a share. Availability rotates, is limited to accredited investors, and is never guaranteed, and securities regulations limit what we can say publicly about specific offerings, including which companies are available at any given time. If you are an accredited investor, contact us and we will talk through whether a position like this fits your overall portfolio.
The practical side is simple. There is no separate platform, no outside login, and no standalone paperwork firm. Eligible clients subscribe through our custodian, Altruist, with digital signatures, fund the investment from cash in their account, and once the subscription settles the position appears on the same statements as their other holdings.
Where Anthropic stands today
Anthropic, the company behind the Claude family of AI models, is still privately held. The company confidentially submitted a draft S-1 registration statement to the SEC on June 1, 2026, which gives it the option to proceed with an IPO once regulatory review is complete. A confidential filing starts the clock, but it does not make the company's financials public and it does not put shares on an exchange.
The private funding history gives you the reference points. Anthropic raised $30 billion in a Series G round at a $380 billion valuation in February 2026, then a $65 billion Series H round in May lifted the valuation to approximately $965 billion. Those are the last prices sophisticated investors paid in company-approved rounds, and they are the only hard valuation marks that exist until a public prospectus prints a price range.
The IPO itself is reported, not confirmed. Anthropic could raise as much as $100 billion in an IPO that would value the company around $2 trillion, according to the Wall Street Journal, and the listing could take place as soon as November. The company has reportedly selected Nasdaq for the listing, but it has not declared a definitive timeline. Treat every date and valuation figure in the press as a report that can move.
Why you cannot buy Anthropic stock before the IPO through normal channels
Private company shares do not trade on an exchange, so there is no ticker to type into a brokerage app. That part is true of every pre-IPO company. What makes Anthropic different is how firmly the company has closed the side doors.
Anthropic says both its preferred and common stock are subject to transfer restrictions, meaning any share sale or transfer not approved by its board of directors is considered invalid. The company went further than most private issuers and named the structures it rejects. Anthropic states that it does not permit special purpose vehicles to acquire its stock and that any transfer of shares to an SPV is void under its transfer restrictions. In May 2026, Anthropic reportedly warned eight secondary-market platforms, including Forge, Hiive and Sydecar, that they were not authorized to facilitate transactions in its shares.
A quick definition for anyone new to this corner of the market. A special purpose vehicle, or SPV, is a fund set up to hold a single investment so that many smaller investors can pool money into it. A forward contract is a private agreement where a shareholder promises to deliver shares at a future date, usually after a lock-up ends, in exchange for cash today. Both are common ways retail money has historically reached hot private companies. Anthropic has said, in writing, that it does not recognize either one.
The practical implication: if a platform, app, or salesperson offers you “pre-IPO Anthropic exposure” through an SPV, a tokenized share, or a forward contract, you are being sold a claim the issuer has declared void. You may end up owning a contract with a counterparty, not equity in Anthropic.
The one path that exists for accredited investors
Board-approved private transfers are the only route to buy Anthropic stock before the IPO that produces recognized equity. These happen when an existing shareholder, typically an early employee or investor, sells shares with the company's sign-off, or when the company itself runs a tender offer that lets existing holders sell to buyers it has selected.
Access is gated two ways. First, federal securities law limits most private-company share purchases to accredited investors. The common qualification tests are a net worth above $1 million excluding your primary residence, or income above $200,000 individually ($300,000 jointly) in each of the last two years with a reasonable expectation of the same this year. Second, Anthropic's board has to approve the specific transfer, and the company has made clear it will not recognize transfers it has not approved.
Even for accredited investors, limited availability means minimum investments may be high and any transaction may be subject to Anthropic's approval and transfer restrictions. In practice this path is limited, and for most investors, including most accredited investors, the door is technically open and practically narrow.
If you are offered a board-approved transfer, the questions that matter are straightforward. Can the seller show the company's written approval? Will the shares be recorded in your name, or a fund's name, on Anthropic's books? What is the all-in price including fees, and how does it compare to the $965 billion Series H mark? What are the lock-up terms after an IPO? A legitimate seller can answer all four.
What the IPO allocation process looks like
The next window opens at the offering itself. Here is how that works for a listing of this size.
Once the public S-1 is filed, the company and its underwriters set a preliminary price range and begin a roadshow, meeting with institutional investors to build the order book. Reuters reported that the company is expected to begin marketing its IPO as early as mid-October 2026. Shares are then allocated at the IPO price, and the overwhelming majority go to institutions: pension funds, mutual fund complexes, sovereign funds, and large asset managers with existing relationships to the underwriting banks.
Some retail brokerages negotiate small allocations for their customers, and a few recent mega-IPOs have included directed share programs for customers or partners. For Anthropic, no percentage of shares reserved for retail investors has been publicly disclosed, and even when brokerages receive allocations, submitting interest does not guarantee shares. If your broker offers an IPO indication-of-interest program, it costs nothing to register, but a registration does not guarantee an allocation.
The first trade on the exchange is the moment the general public can buy. That opening price is set by an auction between buyers and sellers, and it can land anywhere relative to the IPO price. Historically, large, heavily anticipated listings have opened both well above and well below their offer prices, so the first print is not a reliable guide to where the stock settles over the following months.
What the numbers reported so far tell you, and what they do not
Anthropic's reported revenue growth has been rapid. Its annualized revenue run rate reportedly exceeded $65 billion by the end of July 2026, up from approximately $47 billion in May and about $9 billion at the end of 2025. Reporting on the prospectus describes sharply higher revenue alongside large losses and substantial future infrastructure commitments.
That combination of fast top-line growth, heavy spending, and a valuation that reports put near $2 trillion is exactly the kind of profile that produces wide disagreement among analysts. Some see the leading AI model company at the start of a multi-decade cycle. Others see a business whose capital intensity and competition from open-source models make the valuation hard to justify. Both views are in current coverage, and both are working from reported figures rather than the audited prospectus.
This matters for anyone weighing an early purchase. Until the public S-1 is available, the public has not seen the audited financials, the share count, the capital structure, or the full risk factors. Anyone who decides to buy Anthropic stock before the IPO is buying on reports. Once the prospectus is public, you can read the actual numbers and decide with the same information the institutions have.
How Infinitus approaches pre-IPO and IPO opportunities
At Infinitus we build every portfolio from individual securities, so a high-profile IPO is the kind of event we study closely. Our approach is the same for Anthropic as it is for any newly public company: research the business from the prospectus, evaluate the price the market sets against the fundamentals, and decide whether and how a position fits a specific client's custom portfolio, time horizon, and existing concentration.
Structure matters as much as the company. When we look at any pre-IPO or private-company opportunity, we ask the questions listed below: who the counterparty is, whether the investor ends up with recognized equity, what it costs in total, and how and when it can be sold. In Anthropic's case, the issuer has stated that most third-party structures are void, which settles the question for those routes.
We also see the opportunity clearly. If the IPO proceeds as reported, investors who could not access the private rounds would be able to evaluate the company from a public prospectus and, if it fits their goals, own the stock at a price they can see, in an account they control, with daily liquidity.
For clients who want AI exposure today, there are also publicly traded companies that have disclosed significant investments in Anthropic and other frontier AI labs. Those are established businesses with audited financials and daily liquidity, and they belong in a research process like any other individual stock. That is an analytical observation, not a recommendation to buy any specific security.
You can read more about how Infinitus approaches this area on our pre-IPO investing page and our private companies investment strategy page.
Questions to ask before accepting any pre-IPO offer
Whether the offer involves Anthropic or the next headline company, the same diligence applies.
Who is the counterparty, and are they a registered broker-dealer or investment adviser you can verify through FINRA BrokerCheck or the SEC's adviser database?
Will I own shares recorded on the company's books, or an interest in a vehicle that owns something else?
Has the company itself approved this transfer, and can I see that approval in writing?
What is the total cost, including placement fees, management fees, carried interest, and spread above the last company-approved round?
What are the lock-up terms, and when can I actually sell?
What happens to my investment if the IPO is delayed or canceled?
If any answer is vague, that is a signal to pause and ask for the documentation in writing.
The bottom line on whether you can buy Anthropic stock before the IPO
The window before the listing is closed to the general public and narrow for accredited investors. The company has declared SPVs, forward contracts, and unapproved transfers void. The public S-1 has not been released. The IPO is reported for November 2026, with a Nasdaq listing and a reported valuation near $2 trillion, but none of it is confirmed.
What you can do now is prepare. Read the prospectus when it is public. Decide in advance what role, if any, a newly public AI company should play in a portfolio built around your goals. And work with an adviser who evaluates the business on its merits rather than the excitement around it.
If you would like to talk through how we research new public companies and build custom portfolios from individual securities, we would welcome the conversation.
Frequently Asked Questions
Can retail investors buy Anthropic stock before the IPO?
No. Anthropic shares do not trade on any public exchange, and the company has stated that transfers not approved by its board are void. Retail investors can buy once the stock lists, which reports place as soon as November 2026.
Can accredited investors buy Anthropic stock before the IPO?
Only through board-approved private transfers, which require company approval of each transaction and may carry high minimums. SPVs and forward contracts are not recognized by Anthropic.
What is Anthropic's current valuation?
The last company-approved mark is approximately $965 billion from the May 2026 Series H round. Press reports describe an IPO valuation near $2 trillion, which is unconfirmed.
When is the Anthropic IPO?
Anthropic confidentially filed a draft S-1 on June 1, 2026. Reports point to a Nasdaq listing as soon as November 2026, with marketing beginning as early as mid-October. No date has been confirmed by the company.
What happens to pre-IPO shares after the listing?
Shares held by pre-IPO investors are typically subject to a lock-up, commonly 180 days, during which they cannot be sold on the open market.
Is a pre-IPO Anthropic SPV a safe way to get exposure?
Anthropic has stated that transfers of its shares to SPVs are void under its transfer restrictions. An investor in such a vehicle may hold a claim against the vehicle's sponsor rather than equity in Anthropic.
Disclosures
This article is provided for informational and educational purposes only and does not constitute investment, legal, or tax advice, nor an offer, solicitation, or recommendation to buy or sell any security, including shares of Anthropic PBC or any company mentioned. Infinitus Wealth Management is a fee-only registered investment adviser; registration does not imply a certain level of skill or training. Information about Anthropic's valuation, financial results, IPO timing, and transfer restrictions is drawn from public press reports and company statements as of the date above, has not been independently verified, and may change without notice. Anthropic has not publicly released its registration statement, and no information in this article should be understood as a description of that filing. Investing in IPOs and private securities involves substantial risk, including illiquidity, lack of transparency, and the possible loss of the entire investment; private securities are generally available only to accredited investors. Past performance is no guarantee of future results. Infinitus Wealth Management, its principals, and its clients do not hold positions in Anthropic as of the date of publication. Consult your own adviser before making any investment decision.
